Konstantina Panoutsopoulou

5PUBLICATIONS
7CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2025
Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.

Katerina-Marina Pilala, Stella Koroneou, Maria-Alexandra Papadimitriou

|May 17, 2022
Epi-miRNAs: Modern mediators of methylation status in human cancers.

Maria-Alexandra Papadimitriou, Konstantina Panoutsopoulou, Katerina-Marina Pilala

|Jan 11, 2022
tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression.

Konstantina Panoutsopoulou, Tobias Dreyer, Julia Dorn

|Jul 05, 2020
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients.

Konstantina Panoutsopoulou, Margaritis Avgeris, Paraskevi Magkou

|Oct 20, 2018
miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.

Konstantina Panoutsopoulou, Margaritis Avgeris, Andreas Scorilas

Pageof 1